CN103450095A - Mercuric sulfamonomethoxine and preparation method thereof - Google Patents

Mercuric sulfamonomethoxine and preparation method thereof Download PDF

Info

Publication number
CN103450095A
CN103450095A CN2013104097919A CN201310409791A CN103450095A CN 103450095 A CN103450095 A CN 103450095A CN 2013104097919 A CN2013104097919 A CN 2013104097919A CN 201310409791 A CN201310409791 A CN 201310409791A CN 103450095 A CN103450095 A CN 103450095A
Authority
CN
China
Prior art keywords
sulfamonomethoxine
mercury
mercuric
product
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013104097919A
Other languages
Chinese (zh)
Inventor
尹爱萍
伊秀娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013104097919A priority Critical patent/CN103450095A/en
Publication of CN103450095A publication Critical patent/CN103450095A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to sulfonamide transition metal compounds and preparation methods thereof, and specifically relates to mercuric sulfamonomethoxine and a preparation method thereof. The invention mainly solves the technical problem that sulfonamide medicines are poor in antibacterial activity. The technical scheme adopted by the invention is as follows: mercuric sulfamonomethoxine is prepared by synthesizing sulfamonomethoxine and mercuric chloride in ratio of amount of substance of: 2:1. The preparation method comprises the following steps: (1) weighing raw materials according to the ratio of amount of substance of: 2:1 of sulfamonomethoxine toand mercuric chloride; (2) sequentially adding NaOH liquor and sulfamonomethoxine into a container according to the mass ratio of sulfamonomethoxine toand 10% NaOH liquor of (2.9-5.6):10, and stirring to react for 5 hours at normal temperature; (3) preparingproportioning mercuric chloride into 0.255mol/L<-1> mercuric chloride aqueous liquor; (4) adding the mercuric chloride aqueous liquor into the container at 60 DEG C, and insulating to react for 5 hours to generate a mercuric sulfamonomethoxine wet product; (5) decompressing and filtering the produced wet product, washing the product with redistilled water and absolute ethyl alcohol, and vacuum-drying the product at 40 DEG C for 12 hours to obtain the mercuric sulfamonomethoxine product.

Description

A kind of sulfamonomethoxine mercury and preparation method thereof
Technical field
The invention belongs to sulfamido transition metal complex and preparation method thereof, be specifically related to a kind of sulfamonomethoxine mercury and preparation method thereof.
Background technology
Sulfamonomethoxine is a kind of of sulfa drugs, and it has the obstruction effect to folic acid in bacterial body is synthetic, thereby reaches antibacterial effect, belongs to the sulfamido bacteriostatic.But bacterium increases the sulfa drugs resistance in recent years, as in treatment scald and burn, sulfa drugs can not effectively stop the infection of bacterium in scald and burn.
Summary of the invention
The objective of the invention is to solve the sulfa drugs technical problem poor to the biocidal property of bacterium, a kind of sulfamonomethoxine mercury and preparation method thereof is provided, the present invention has good biocidal property to intestinal bacteria, streptococcus aureus, Bacillus subtilus, and the preparation method is simple, with low cost, be easy to industrialization.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A kind of sulfamonomethoxine mercury, it is with mercury chloride, by the amount of substance ratio, to be that the 2:1 chemosynthesis makes by sulfamonomethoxine, the structural formula of sulfamonomethoxine mercury is:
Figure BDA00003802320800011
Molecular formula is: C 22h 22n 8o 6s 2hg.
The preparation method of above-mentioned sulfamonomethoxine mercury, its preparation process is: 1. according to sulfamonomethoxine and mercury chloride amount of substance ratio, for 2:1, take each raw material; The NaOH solution that the proportioning that the mass ratio of the NaOH solution that is 2. 10% according to sulfamonomethoxine and concentration is 2.9~5.6:10 is 10% by concentration is put into reaction vessel, then sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h at normal temperatures; 3. mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the temperature of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h obtain sulfamonomethoxine mercury product.
For showing the bacteriostasis property of the present invention to intestinal bacteria, streptococcus aureus, Bacillus subtilus, adopt the In Vitro Bacteriostasis test.
1. medicine and bacterial strain
The self-control of sulfamonomethoxine mercury, Gram-negative bacteria, gram-positive microorganism all are purchased from Qingdao GaoKeYuan Hai Bo Bioisystech Co., Ltd.
2. method
The microbial culture plate is put 37 ℃ and is cultivated 24h, and 28 ℃ of cultivation 24h of fungi, adopt nutrient broth By Dilution SMD, HgCl 2and the minimum inhibitory concentration of SMD-Hg (II), observations, data see the following form 1.
Figure BDA00003802320800021
Table 1SMD, HgCl 2and the minimum inhibitory concentration (MIC) of SMD-Hg (II)/mgmL -1
From minimum inhibitory concentration, bacterium class title complex minimum inhibitory concentration all is less than part, show that title complex is better than part to each bacterial classification bacteriostasis property, illustrate that the sulfamonomethoxine hydrargyrum complex has good biocidal property to intestinal bacteria, streptococcus aureus, Bacillus subtilus.
Embodiment
Embodiment 1
Sulfamonomethoxine mercury in the present embodiment, it is with mercury chloride, by the amount of substance ratio, to be that the 2:1 chemosynthesis makes by sulfamonomethoxine, the structural formula of sulfamonomethoxine mercury is:
Figure BDA00003802320800031
Molecular formula is: C 22h 22n 8o 6s 2hg.
The preparation method of above-mentioned sulfamonomethoxine mercury, its preparation process is: 1. take raw material sulfamonomethoxine 2.90g and mercury chloride 1.40g; 2. the NaOH solution that is 10% by 10g concentration is put into reaction vessel, then the 2.90g sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h at normal temperatures; 3. 1.40g mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the water-bath of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h, obtain sulfamonomethoxine mercury product 2.51g, productive rate 66.15%.
Embodiment 2
Sulfamonomethoxine mercury in the present embodiment is identical with the sulfamonomethoxine mercury in embodiment 1.
The preparation method of above-mentioned sulfamonomethoxine mercury, its preparation process is: 1. take raw material sulfamonomethoxine 3.48g and mercury chloride 1.69g; 2. the NaOH solution that is 10% by 10g concentration is put into reaction vessel, then the 3.48g sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h at normal temperatures; 3. 1.69g mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the water-bath of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h, obtain sulfamonomethoxine mercury product 3.15g, productive rate 69.97%.
Embodiment 3
Sulfamonomethoxine mercury in the present embodiment is identical with the sulfamonomethoxine mercury in embodiment 1.
The preparation method of above-mentioned sulfamonomethoxine mercury, its preparation process is: 1. take raw material sulfamonomethoxine 4.26g and mercury chloride 2.06g; 2. the NaOH solution that is 10% by 10g concentration is put into reaction vessel, then the 4.26g sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h under normal temperature environment; 3. 2.06g mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the water-bath of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h, obtain sulfamonomethoxine mercury product 3.15g, productive rate 55.42%.
Embodiment 4
Sulfamonomethoxine mercury in the present embodiment is identical with the sulfamonomethoxine mercury in embodiment 1.
The preparation method of above-mentioned sulfamonomethoxine mercury, its preparation process is: 1. take raw material sulfamonomethoxine 5.60g and mercury chloride 2.70g; 2. the NaOH solution that is 10% by 10g concentration is put into reaction vessel, then the 5.60g sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h under normal temperature environment; 3. 2.70g mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the temperature of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h, obtain sulfamonomethoxine mercury product 7.10g, productive rate 93.66%.
Protection scope of the present invention is not subject to the restriction of above embodiment.

Claims (2)

1. a sulfamonomethoxine mercury, it is characterized in that: it is with mercury chloride, by the amount of substance ratio, to be that the 2:1 chemosynthesis makes by sulfamonomethoxine, and the structural formula of sulfamonomethoxine mercury is:
Figure FDA00003802320700011
Molecular formula is: C 22h 22n 8o 6s 2hg.
2. the preparation method of a sulfamonomethoxine mercury, is characterized in that: 1. according to sulfamonomethoxine and mercury chloride amount of substance ratio, for 2:1, take each raw material; The NaOH solution that the proportioning that the mass ratio of the NaOH solution that is 2. 10% according to sulfamonomethoxine and concentration is 2.9~5.6:10 is 10% by concentration is put into reaction vessel, then sulfamonomethoxine is added in container, and magnetic agitation is reacted 5h at normal temperatures; 3. mercury chloride is dissolved in redistilled water to be made into concentration be 0.255molL -1mercuric chloride solution; 4. reaction vessel is placed in to the temperature of 60 ℃, continues to stir, mercuric chloride solution is slowly at the uniform velocity added in reaction vessel, insulation reaction 5h, generate a large amount of pale precipitations and be sulfamonomethoxine mercury wet product; 5. sulfamonomethoxine mercury wet product filtration under diminished pressure reaction generated, use the second distillation water washing, then use absolute ethanol washing, and 40 ℃ of vacuum-drying 12h obtain sulfamonomethoxine mercury product.
CN2013104097919A 2013-09-11 2013-09-11 Mercuric sulfamonomethoxine and preparation method thereof Pending CN103450095A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013104097919A CN103450095A (en) 2013-09-11 2013-09-11 Mercuric sulfamonomethoxine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013104097919A CN103450095A (en) 2013-09-11 2013-09-11 Mercuric sulfamonomethoxine and preparation method thereof

Publications (1)

Publication Number Publication Date
CN103450095A true CN103450095A (en) 2013-12-18

Family

ID=49732987

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013104097919A Pending CN103450095A (en) 2013-09-11 2013-09-11 Mercuric sulfamonomethoxine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103450095A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111606933A (en) * 2020-06-30 2020-09-01 洛阳师范学院 Phenanthroline ligand-containing Cd (II) complex and preparation method and application thereof
CN112079852A (en) * 2020-08-21 2020-12-15 洛阳师范学院 Zn (II) complex based on ASBSA and 4, 4' bipyridyl ligand and preparation method and application thereof
CN114716388A (en) * 2021-11-04 2022-07-08 江苏冠军科技集团股份有限公司 Sulfanilamide-silver compound and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006674A (en) * 2012-12-14 2013-04-03 江苏恒丰强生物技术有限公司 Compound sulfamonomethoxine sodium solution and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006674A (en) * 2012-12-14 2013-04-03 江苏恒丰强生物技术有限公司 Compound sulfamonomethoxine sodium solution and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANGEL GARCIA-RASO,ETAL: "Coordination behaviour of sulfanilamide derivatives. Crystal structures of [Hg(sulfamethoxypyridazinato)2], [Cd(sulfadimidinato)2(H2O)] 2H2O and[Zn(sulfamethoxazolato)2-(pyridine)2(H2O)2]", 《POLYHEDRON》, no. 19, 31 December 2000 (2000-12-31), pages 991 - 1004 *
ANGEL GARCIA-RASO,ETAL: "Metallation of 2-sulfanilamidopyrimidine (sulfadiazine).X-ray diffraction structure and solution behaviour of bis(sulfadiazinato) mercury bis(dimethylsulfoxide)", 《POLYHEDRON》, vol. 16, no. 4, 31 December 1997 (1997-12-31), pages 613 - 621, XP005504685, DOI: doi:10.1016/0277-5387(96)00317-8 *
G.M.GOLZAR HOSSAIN,ETAL: "Syntheses and characterisation of mercury complexes of sulfadiazine, sulfamerazine and sulfamethazine", 《POLYHEDRON》, no. 26, 31 December 2007 (2007-12-31), pages 967 - 974 *
尹爱萍: "磺胺间甲氧嘧啶过渡金属配合物的制备及其表征", 《内蒙古石油化工》, no. 18, 30 September 2011 (2011-09-30), pages 4 - 6 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111606933A (en) * 2020-06-30 2020-09-01 洛阳师范学院 Phenanthroline ligand-containing Cd (II) complex and preparation method and application thereof
CN112079852A (en) * 2020-08-21 2020-12-15 洛阳师范学院 Zn (II) complex based on ASBSA and 4, 4' bipyridyl ligand and preparation method and application thereof
CN112079852B (en) * 2020-08-21 2023-01-10 洛阳师范学院 Zn (II) complex based on ASBSA and 4,4' bipyridine ligand and preparation method and application thereof
CN114716388A (en) * 2021-11-04 2022-07-08 江苏冠军科技集团股份有限公司 Sulfanilamide-silver compound and preparation method thereof
CN114716388B (en) * 2021-11-04 2024-02-13 江苏冠军科技集团股份有限公司 Sulfonamide-silver compound and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102875574A (en) Crystal form of ceftriaxone sodium and preparation method for crystal form
CN105061632B (en) The preparation method and bacteriostasis property of a kind of curdlan quaternary ammonium salt
CN103881010A (en) Borneol-based macromolecule antibacterial material
KR20140118294A (en) Graphene-based antibacterial composite and method for production thereof
Song et al. Synthesis, antimicrobial, moisture absorption and retention activities of kojic acid-grafted konjac glucomannan oligosaccharides
CN103450095A (en) Mercuric sulfamonomethoxine and preparation method thereof
CN102232609A (en) Pectin hydrolysate natural food preservative and method for preparing same
CN104558244B (en) A kind of O-pyridine acid esters chitosan and preparation method and application
CN103642070A (en) Antibiotic composite membrane of nano-silk fibroin-chitosan-nano-silver
CN105669712A (en) N-heterocyclic carbene silver complexes with antibiosis bioactivity, and preparation method thereof
El-Newehy et al. Biocidal polymers: Preparation and antimicrobial assessment of immobilized onium salts onto modified chitosan
CN101367800A (en) Synthesis of tubercle bacillus resistant medicament 3-alkoxyl-8-alkyl -12-R3-jatrorrhizine salt and uses thereof
CN103589709A (en) Method for improving capacity of ferulic acid modified lysozyme for restraining gram-negative bacteria
CN104988083B (en) Streptomyces platensis and its application in terms of producing plate mycin peace laminin
CN103374019B (en) A kind of preparation method of Cefuroxime Sodium
CN102669581A (en) Preparation method of bacillus natto freeze-dried powder for making natto at home
CN112175053A (en) Bacteriocin produced by lactobacillus acidophilus NM, preparation method and application thereof
CN106635880B (en) It is resistant to the E. coli mutant strain of phenyl-lactic acid, application and its synthetic method in synthesis of phenyl lactic acid
CN104151371A (en) N-acetylglucosamine-N&#39;-acylamino thiourea as well as synthesis method and application thereof
CN105503841B (en) A kind of aminocarbazole furfural derivative and its application
CN102232955B (en) The preparation method of amorphous cefuroxin axetil Perorally administrable antimicrobial composition and the compositions of preparation, compound preparation
CN103450278B (en) Water-soluble carbon monoxide-releasing molecules and its preparation method and application
CN104892692A (en) 6-amino-6-deoxy-trehalose as well as preparation and application thereof
CN102276539B (en) Bacteriostatic compound and preparation method thereof
AU2016102314A4 (en) Ceftezol drug intermediates 2-(1H-1-4 imidazolyl) acetic acid synthesis method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20131218